VCP746: a cardioprotective adenosine receptor agonist with minimal haemodynamic effects

被引：0
|
作者：
Chuo, C. H. [1 ]
May, L. T. [1 ]
Scammells, P. [1 ]
Wang, B. H. [1 ]
Krum, H. [1 ]
Kompa, A. R. [1 ]
White, P. J. [1 ]
机构：
[1] Monash Univ, Melbourne, Vic 3004, Australia
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4521
引用
收藏
页码：776 / 776
页数：1
相关论文
共 50 条
  • [1] Renal ischemia reperfusion injury is reduced by the adenosine receptor agonist VCP746
    Seibt, Benjamin
    Lu, Bo
    Roberts, Veena
    Fang, Doreen
    Cowan, Peter
    Dwyer, Karen
    [J]. PURINERGIC SIGNALLING, 2014, 10 (04) : 682 - 683
  • [2] THE NOVEL ADENOSINE RECEPTOR AGONIST VCP746 REDUCES RENAL ISCHAEMIA REPERFUSION INJURY
    Benjamin, Seibt
    Bo, Lu
    Doreen, Fang
    Veena, Roberts
    Lauren, May
    Peter, Cowan
    Karen, Dwyer
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2014, 92 (08): : A20 - A20
  • [3] VCP746 as an agonist for the adenosine A2A, A2B, and A3 receptors
    Sabbatini, A. R.
    Stoddart, L.
    Arruda, M.
    Hill, S.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (16) : 3030 - 3030
  • [4] VCP746, a novel A1 adenosine receptor biased agonist, reduces hypertrophy in a rat neonatal cardiac myocyte model
    Chuo, Chung H.
    Devine, Shane M.
    Scammells, Peter J.
    Krum, Henry
    Christopoulos, Arthur
    May, Lauren T.
    White, Paul J.
    Wang, Bing H.
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2016, 43 (10): : 976 - 982
  • [5] The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling
    Vecchio, Elizabeth A.
    Chuo, Chung Hui
    Baltos, Jo-Anne
    Ford, Leigh
    Scammells, Peter J.
    Wang, Bing H.
    Christopoulos, Arthur
    White, Paul J.
    May, Lauren T.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2016, 117 : 46 - 56
  • [6] The effect of two selective A1-receptor agonists and the bitopic ligand VCP746 on heart rate and regional vascular conductance in conscious rats
    Cooper, Samantha L.
    March, Julie
    Sabbatini, Andrea R.
    Hill, Stephen J.
    Jorg, Manuela
    Scammells, Peter J.
    Woolard, Jeanette
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (02) : 346 - 359
  • [7] Cardioprotective effects of the novel adenosine A1/A2 receptor agonist, AMP 579.
    McVey, M
    Smits, GJ
    Cox, BF
    Perrone, MH
    Clark, KL
    [J]. FASEB JOURNAL, 1998, 12 (04): : A78 - A78
  • [8] Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats
    Nekooeian, AA
    Tabrizchi, R
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (04) : 651 - 658
  • [9] Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction
    Smits, GJ
    McVey, M
    Cox, BF
    Perrone, MH
    Clark, KL
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (02): : 611 - 618
  • [10] A Retinoic Acid β2-Receptor Agonist Exerts Cardioprotective Effects
    Marino, Alice
    Sakamoto, Takuya
    Tang, Xiao-Han
    Gudas, Lorraine J.
    Levi, Roberto
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 366 (02): : 314 - 321
12345